-
Loading metrics
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy
- Zongwei Wang,
- Tuo Deng,
- Xingbo Long,
- Xueming Lin,
- Shulin Wu,
- Hongbo Wang,
- Rongbin Ge,
- Zhenwei Zhang,
- Chin-Lee Wu,
- Mary-Ellen Taplin
x
- Published: March 5, 2020
- https://doi.org/10.1371/journal.pone.0229754